ctrl K

Price Alert

Entrada Therapeutics Inc. (TRDA)

NASDAQ: TRDA · Real-Time Price · USD

5.29

0.04 (0.76%)

At close: Aug 15, 2025, 3:59 PM

5.27

-0.28%

After-hours: Aug 15, 2025, 04:10 PM EDT

Entrada Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	101.21M	67.6M	45.16M	291.06M
Short-Term Investments	318.79M	284.37M	143.56M	n/a
Long-Term Investments	n/a	n/a	3.95M	n/a
Other Long-Term Assets	4.23M	6.74M	5.21M	872K
Receivables	3.68M	5.88M	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	16.36M	11.92M	21.16M	n/a
Total Current Assets	440.04M	369.77M	209.88M	298.7M
Property-Plant & Equipment	82.05M	92.68M	33.02M	6.26M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	86.28M	99.42M	42.18M	7.13M
Total Assets	526.32M	469.19M	252.06M	305.83M
Account Payables	4.26M	3.28M	5.99M	706K
Deferred Revenue	13.65M	132.26M	n/a	n/a
Short-Term Debt	n/a	7.02M	8.41M	n/a
Other Current Liabilities	8.43M	11.69M	-2.91M	485K
Total Current Liabilities	39.48M	158.8M	21.97M	6.72M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	6.51M	n/a	n/a	396K
Total Long-Term Liabilities	58.16M	68.04M	17.53M	396K
Total Liabilities	97.64M	226.83M	39.5M	7.12M
Total Debt	59.21M	68.23M	25.94M	n/a
Common Stock	4K	3K	3K	3K
Retained Earnings	-129.34M	-194.97M	-188.28M	-93.67M
Comprehensive Income	-43K	195K	-2.06M	-305.83M
Shareholders Equity	428.68M	242.36M	212.55M	298.72M
Total Investments	318.79M	284.37M	143.56M	n/a